Functional target volume delineation for radiation therapy on the basis of positron emission tomography and the correlation with histopathology

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 54, Issue 5, 2010, Pages 490-499

  Thorwarth, D ^a   Schaefer, A ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Algorithms; Diagnostic imaging; Positron emission tomography; Radiotherapy

Indexed keywords

ACCURACY; ALGORITHM; AUTOMATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; HISTOPATHOLOGY; HUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT PLANNING; TUMOR VOLUME; VALIDATION STUDY;

ALGORITHMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS;

EID: 79251489816     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. ICRU Prescribing, recording and reporting photon beam therapy. Supplement to report 50; 1999.
2. Nestle U, Weber W, Hentschel M, Grosu AL. Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol 2009;54:R1-25.
3. Ling CC, Humm J, Larson S, Amols H, Fuks Z, Leibel S et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000;47:551-60.
4. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S-93S.
5. Baum RP, Hellwig D, Mezzetti M. Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer. Q J Nucl Med Mol Imaging 2004;48:119-42.
6. Kirby AM, Mikhaeel NG. The role of FDG PET in the management of lymphoma: what is the evidence base? Nucl Med Commun 2007;28:335-54.
7. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of Spetember 2006. J Nucl Med 2007;48:78S-88S.
8. Zaidi H, Alavi A. Current trends in PET and combined (PET/CT and PET/MR) system design. PET Clinics 2007;2:109-23.
9. MacManus M, Nestle U, Rosenzweig KE, Carrio I, Messa C, Belohlavek O et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 2009;91:85-94.
10. Nestle U, Kremp S, Grosu AL. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 2006;81:209-25.
11. Pötzsch C, Hofheinz F, van den Hoff J. Vergleich der Inter-Observer-Variabilität bei manueller und automatischer Volumenbestimmung in der PET. Nuklearmedizin 2006;45:A42.
12. van Baardwijk A, Bosmans G, Boersma L, Buijsen J, Wanders S, Hochstenbag M et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 2007;68:771-8.
13. Caldwell CB, Mah K, Ung YC, Danjoux CE, Balogh JM, Ganguli SN et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 2001;51:923-31.
14. Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 1997;80:2505-9.
15. Schaefer A, Kremp S, Hellwig D, Rübe C, Kirsch CM, Nestle U. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging 2008;35:1989-99.
16. Daisne JF, Sibomana M, Bol A, Doumont T, Lonneux M, Grégoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 2003;69:247-50.
17. van Dalen JA, Hoffmann AL, Dicken V, Vogel WV, Wiering B, Ruers TJ et al. A novel iterative method for lesion delineation and volumetric quantification with FDG PET. Nucl Med Commun 2007;28:485-93.
18. Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 2004;60:1272-82.
19. Li H, Thorstad WL, Biehl KJ, Laforest R, Su Y, Shoghi KI et al. A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Med Phys 2008;35:3711-21.
20. Day E, Betler J, Parda D, Reitz B, Kirichenko A, Mohammadi S et al. A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients. Med Phys 2009;36:4349-58.
21. Geets X, Lee JA, Bol A, Lonneux M, Gregoire V. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging 2007;34:1427-38.
22. Hatt M, Cheze le Rest C, Turzo A, Roux C, Visvikis D. A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET. IEEE Trans Med Imaging 2009;28:881-93.
23. Paulino AC, Johnstone PA. FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys 2004;59:4-5.
24. Knight SB, Delbeke D, Stewart JR,Sandler MP. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996;109:982-8.
25. Hellwig D, Graeter TP, Gröschel A, Sybrecht GW, Schäfers HJ, Kirsch CM. FDG-PET for mediastinal staging of lung cancer: Which SUV threshold makes sense? J Nucl Med 2007;48:1761-6.
26. Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med 2005;46:1342-8.
27. Nestle U, Schaefer-Schuler A, Kremp S, Groeschel A, Hellwig D, Rübe C et al. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2007;34:453-62.
28. Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004;45:1519-527.
29. Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values. J Nucl Med 2005;46:424-8.
30. Menda Y, Bushnell DL, Madsen MT, McLaughlin K, Kahn D, Kernstine KH. Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy. Nucl Med Commun 2001;22:1077-81.
31. 18F-FDG: standardized uptake values in normal tissues. J Nucl Med 2004;45:784-8.
32. Bradley J, Thorstad WL, Mutic S, Miller TR, Dhdashti F, Siegel BA et al. Impact of FDG-PFT on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;59:78-86.
33. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 2002;53;353-9.
34. Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D et al. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 2004;45:543-52.
35. Sura S, Greco C, Gelblum D, Yorke ED, Jackson A, Rosenzweig KE. (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1397-402.
36. Erdi YE, Rosenzweig K, Erdi AK, Macapinlac HA, Hu YC, Braban LE et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002;62:51-60.
37. Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 2006;47:1808-12.
38. Ford EC, Kinahan PE, Hanlon L, Alessio A, Rajendran J, Schwartz DL et al. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. Med Phys 2006;33:4280-8.
39. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004;233:93-100. Erratum in: Radiology 2005;235:1086.
40. Hellwig D, Nestle U, Fleckenstein J, Schäfer-Schuler A, Kremp S, Gröschel A et al. Dosiseskalierte simultane Radiochemotherapie (RCT) des nicht-kleinzelligen Bronchialkarzinoms (NSCLC) mit F-18-FDG-PET-basierter konformaler 3D-Planung: Ergebnisse der PET-PLAN Pilotstudie. Nuklearmedizin 2009;48:V11.
41. Nehmeh SA, El-Zeftawy H, Greco C, Schwartz J, Erdi YE, Kirov A et al. An iterative technique to segment PET lesions using a Monte Carlo based mathematical model. Med Phys 2009;36:4803-9.
42. Bayne M, MacManus M, Hicks R, Leong T, Peters L, Ball D. Can a mathematical formula help define a radiation target volume using positron emission tomography? Int J Radiat Oncol Biol Phys 2005;62:299-300; author reply 300.
43. Geets X, Tomsej M, Lee JA, Duprez T, Coche E, Cosnard G et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumours: impact on target volume delineation and dose distribution using helical tomotherapy. Radiother Oncol 2007;85:105-15.
44. Hatt M, Cheze le Rest C, Descourt P, Dekker A, De Ruysscher D, Oellers M et al. Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications. Int J Radiat Oncol Biol Phys 2010;77:301-8.
45. Hatt M, Lamare F, Boussion N, Turzo A, Collet C, Salzenstein F et al. Fuzzy hidden Markov chains segmentation for volume determination and quantitation in PET. Phys Med Biol 2007;52:3467-91.
46. Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF et al. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET. J Nucl Med 2008;49:892-8.
47. Janssen MH, Aerts HJ, Ollers MC, Bosmans G, Lee JA, Buijsen J et al. Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patients. Int J Radiat Oncol Biol Phys 2009;73:456-5.
48. Thorwarth D, Eschmann SM, Paulsen F, Alber M. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys 2007;68:291-300.
49. Mamede M, El Fakhri G, Abreu-e-Lima P, Gandler W, Nosé V, Gerbaudo VH. Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation. Ann Nucl Med 2007;21:553-62.
50. Wu K, Ung YC, Hornby J, Freeman M, Hwang D, Tsao MS et al. PET CT Thresholds for Radiotherapy Target Definition in Non-Small-Cell Lung Cancer: How Close are we to the Pathologic Findings? Int J Radiat Oncol Biol Phys 2010;77:699-706.
51. Vees H, Senthamizhchelvan S, Miralbell R, Weber DC, Ratib O, Zaidi H. Assessment of various strategies for 18F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging 2009;36:182-93.
52. Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders JH. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:1282-9.
53. Greco C, Nehmeh SA, Schöder H, Gönen M, Raphael B, Stambuk HE et al. Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer. Am J Clin Oncol 2008;31:439-45.
54. Steenbakkers RJ, Duppen JC, Fitton I, Deurloo KE, Zijp LJ, Comans EF et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 2006;64:435-48.
55. Van de Steene J, Linthout N, de Mey J, Vinh-Hung V, Claassens C, Noppen M et al. Definition of gross tumor volume in lung cancer: inter-observer variability. Radiother Oncol 2002;62:37-49.
56. van Dalen JA, Vogel WV, Corstens FH, Oyen WJ. Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations. Cancer Imaging 2007;7:77-83.
57. Hoetjes NJ, van Velden FH, Hoekstra OS, Hoekstra CJ, Krak NC, Lammertsma AA et al. Partial volume correction strategies for quantitative FDG PET in oncology. Eur J Nucl Med Mol Imaging 2010;37:1679-87.
58. Barbee DL, Flynn RT, Holden JE, Nickles RJ, Jeraj R. A method for partial volume correction of PET-imaged tumor heterogeneity using expectation maximization with a spatially varying point spread function. Phys Med Biol 2010;55:221-36.
59. De Bernardi E, Faggiano E, Zito F, Gerundini P, Baselli G. Lesion quantification in oncological positron emission tomography: a maximum likelihood partial volume correction strategy. Med Phys 2009;36:3040-9.
60. Grgic A, Nestle U, Schaefer A, Kremp S, Kirsch CM, Hellwig D. FDG-PET based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning - an intraindividual comparison. Int J Radiat Oncol Biol Phys 2009;73:103-111.
61. Castadot P, Geets X, Lee JA, Christian N, Grégoire V. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. Radiother Oncol 2010;95:209-17.
62. Thorwarth D, Soukup M, Alber M. Dose painting with IMPT, helical tomotherapy amd IMXT: a dosimetric comparison. Radiother Oncol 2008;86:30-4.
63. Flynn RT, Bowen SR, Bentzen SM, Rockwell Mackie T, Jeraj R. Intensity-modulated X-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol 2008;53:4153-67.